Last reviewed · How we verify
NCT05496049
Efficacy of Triburter on Respiratory Muscle Function in Patients After CABG in Cardiac Rehabilitation Phase II
NA trial testing Triburter in Thoracic Surgery in 30 participants. Completed in 23 December 2023.
23 December 2023
Quick facts
| Lead sponsor | Fundación Cardiovascular de Colombia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 August 2022 |
| Primary completion | 23 December 2023 |
| Estimated completion | 23 December 2023 |
| Sites | 1 location across Colombia |
Drugs / interventions tested
- Triburter
- Incentive spirometry
Conditions studied
- Thoracic Surgery — all drugs for Thoracic Surgery →
- Postoperative Period — all drugs for Postoperative Period →
- Weakness, Muscle — all drugs for Weakness, Muscle →
Sponsor
Fundación Cardiovascular de Colombia — full company profile →
Who can join
Adults 18 to 100, any sex, with Thoracic Surgery or Postoperative Period. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Post-surgery patients have muscle impairments, especially in the respiratory muscles, because the anesthesia, surgical incision, mechanical ventilation, pain, and prolonged postures, affect the mechanical condition of respiratory muscles. Those consequences produce a low exercise tolerance and low quality of life. These patients must go to cardiac rehabilitation to improve heart functions; however, these patients have a weakness in their respiratory muscles. Currently, there are many devices for respiratory muscle strength, although these devices are expensive, and they only have one circuit for training (inspiratory or expiratory). Triburter is a new device with two valves and positive pressure generation, this is a promising alternative because Triburter improves the mechanics of ventilation, increasing their functionality and quality of life. For this reason, the main hypothesis is that respiratory muscle training with Triburter improves the strength of inspiratory and expiratory muscles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05496049
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thoracic Surgery
Currently open trials in the same condition.
- NCT07392086 — Comparison of FCV and VCV in One-Lung Ventilation · recruiting
- NCT07228598 — Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance · recruiting
- NCT07063602 — Sensory Anesthesia Achieved Through Different Paravertebral Block Approaches for Post-Op Pain Management After VATS Lung · recruiting
- NCT06732193 — Fissios© and Postoperative Complications (FPoC Trial) · NA · recruiting
- NCT06417996 — Biobeat Digital Home Monitoring Feasibility · NA · recruiting
Other Fundación Cardiovascular de Colombia trials
Trials by the same sponsor.
- NCT07033520 — Effects of Online Mindfulness Therapy on Pain and Stress in Adults With Chronic Migraine and Adverse Childhood Experienc · NA · not yet recruiting
- NCT06895005 — Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Stroke · NA · not yet recruiting
- NCT04877171 — Telemedicine Efficacy in Medication Adherence in Post-ischemic Stroke Patients · NA · unknown
- NCT04377386 — Efficacy of Oral Vitamin D Supplementation in Adolescents and Young Adults. · NA · completed
- NCT04668742 — Efficacy and Safety of the DYNAtraq Device to Prevent Complications in Tracheostomy in Mechanically Ventilated Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05496049 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Cardiovascular de Colombia
- Last refreshed: 3 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05496049.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing